Stem cell hope for Parkinson's: safety trial in older adults
NCT ID NCT04772378
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 18 times
Summary
This study tested the safety of giving stem cells through an IV to 10 people aged 76-95 with Parkinson's disease. The treatment involved multiple infusions over 18 weeks, using the patients' own stored stem cells. The goal was to see if this approach is safe, not to cure the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hope Biosciences Stem Cell Research Foundation
Sugar Land, Texas, 77478, United States
Conditions
Explore the condition pages connected to this study.